CoChat

Protein kinase Cδ and c‐Abl kinase are required for transforming growth factor β induction of endothelial–mesenchymal transition in vitro

Open access
Li, Zhaodong, Jimenez, Sergio A. · 2011 · Arthritis & Rheumatism
Cited by 99

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Objective: The origin of the mesenchymal cells responsible for the intimal fibrosis in systemic sclerosis (SSc) has not been fully identified. The present study was undertaken to investigate whether subendothelial mesenchymal cells may emerge through transdifferentiation of endothelial cells (ECs) into myofibroblasts via endothelial–mesenchymal transition (EndoMT) in vitro and to explore the signaling pathways involved in this process. Methods: Primary mouse pulmonary ECs isolated by immunomagnetic methods with sequential anti‐CD34 and anti‐CD102 antibody selection were cultured in monolayers. Cell morphology and diacetylated low‐density lipoprotein uptake assays confirmed their EC characteristics. The induction of EndoMT was assessed by determination of α‐smooth muscle actin (α‐SMA), type I collagen, and VE‐cadherin expression, and the expression of the transcriptional repressor Snail‐1 was analyzed. The signaling pathways involved were examined using small‐molecule kinase inhibitors and RNA interference. Results: Transforming growth factor β1 (TGFβ1) induced α‐SMA and type I collagen expression and inhibited VE‐cadherin. These effects were mediated by a marked increase in Snail‐1 expression and were abolished by treatment with either the c‐Abl tyrosine kinase inhibitor imatinib mesylate or the protein kinase Cδ (PKCδ) inhibitor rottlerin. The inhibitory effects of imatinib mesylate and rottlerin were mediated by inhibition of phosphorylation of glycogen synthase kinase 3β at residue Ser 9. These observations were confirmed in experiments using small interfering RNA specific for c‐Abl and PKCδ. Conclusion: These results indicate that c‐Abl and PKCδ are crucial for TGFβ‐induced EndoMT and that imatinib mesylate and rottlerin or similar kinase inhibitor molecules may be effective therapeutic agents for SSc and other fibroproliferative vasculopathies in which EndoMT plays a pathogenetic role.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.30317

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

Metadata

Authors
Li, Z., & Jimenez, S. A.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2011-08
Volume
63
Issue
8
Pages
2473-2483
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2023116679
Cited by
99
References
4
FWCI
3.53
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.